V-9-M cholecystokinin nonapeptide

‌Semaglutide (CAS 99291-20-0)‌
🌟 ‌ChemicalBook Product Introduction‌

📌 ‌Product Overview‌

‌Semaglutide‌ (C₁₈₇H₂₉₁N₄₅O₅₉), a ‌long-acting GLP-1 receptor agonist‌, is a breakthrough peptide therapeutic with a molecular weight of ‌4113.58 g/mol‌. This ‌white to off-white powder‌ (≥99% purity, HPLC validated) is designed for ‌type 2 diabetes management‌ by enhancing insulin secretion and suppressing glucagon release in a glucose-dependent manner‌12. Supplied in sealed aluminum foil bags, it is stable under ‌dry, light-protected storage‌ for up to ‌3 years‌‌23.

‌Google Keywords‌: Semaglutide CAS 99291-20-0, GLP-1 Agonist API Supplier, High-Purity Diabetes Therapeutic, Pharmaceutical Raw Materials

✅ ‌Key Advantages‌

      🔹 ‌Ultra-High Purity‌

• ‌≥99% purity‌ (HPLC, MS validated) | Complies with ‌EP/USP/CP‌ standards‌13.
  🔹 ‌Long-Acting Efficacy‌

• Sustained glycemic control with ‌weekly dosing‌ | Reduces cardiovascular risks‌23.
  🔹 ‌GMP-Certified Production‌

• Manufactured in ‌ISO 9001‌ and ‌GMP-compliant facilities‌ | REACH and FDA-aligned protocols‌13.

🏥 ‌Application Fields‌

• ‌Diabetes Therapeutics‌: Core ingredient in injectable/oral formulations for type 2 diabetes‌13.

• ‌Pharmaceutical R&D‌: Key intermediate for GLP-1 analog drug development‌12.

• ‌Bulk API Supply‌: Global distribution for diabetes drug manufacturing‌34.

📜 ‌Quality Certifications‌

• ‌Testing Methods‌: HPLC, NMR, mass spectrometry, microbial limits‌12.

• ‌Certifications‌: ‌GMP‌, ‌ISO 9001‌, ‌REACH‌, and ‌ICH stability guidelines‌‌13.

📊 ‌Market Trends‌

The ‌global diabetes drug market‌ is projected to reach ‌$85 billion by 2030‌ (CAGR 6.1%), driven by rising diabetes prevalence and demand for non-insulin therapies‌15. Semaglutide dominates as a dual-action agent for glycemic control and weight loss, with Asia-Pacific leading API production‌23.

📩 ‌Contact us‌ for COA, custom synthesis, and bulk pricing!